[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Laboratory Corp of America (LH)

Laboratory Corp of America (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is Labcorp Holdings Stock Underperforming the Nasdaq?

Labcorp Holdings has underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

$NASX : 26,517.93 (unch)
DGX : 195.00 (-1.40%)
LH : 255.82 (-1.44%)
2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges

2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges

INCY : 98.22 (-0.78%)
LH : 255.82 (-1.44%)
FICO : 1,096.48 (-2.69%)
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members

LH : 255.82 (-1.44%)
3 Cash-Producing Stocks That Concern Us

3 Cash-Producing Stocks That Concern Us

GM : 79.29 (-0.36%)
WEX : 127.53 (+0.53%)
LH : 255.82 (-1.44%)
Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects

New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment

LH : 255.82 (-1.44%)
What Are Wall Street Analysts' Target Price for Labcorp Holdings Stock?

Labcorp Holdings has lagged behind the broader market over the past year, yet analysts remain highly optimistic about the stock’s prospects.

XLV : 149.40 (-0.87%)
$SPX : 7,500.58 (unch)
LH : 255.82 (-1.44%)
Labcorp Launches MyLabcorpâ„¢, a New AI-Powered Mobile App Designed to Help Consumers Understand Lab Results and Track Health Trends Over Time

BURLINGTON, N.C. , May 20, 2026 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of MyLabcorp ...

LH : 255.82 (-1.44%)
3 Profitable Stocks We Find Risky

3 Profitable Stocks We Find Risky

BBCP : 10.91 (-0.64%)
SHOO : 44.19 (+3.15%)
LH : 255.82 (-1.44%)
3 Healthcare Stocks We Steer Clear Of

3 Healthcare Stocks We Steer Clear Of

STAA : 29.12 (-0.34%)
WST : 327.95 (+1.35%)
LH : 255.82 (-1.44%)
The 5 Most Interesting Analyst Questions From Labcorp’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Labcorp’s Q1 Earnings Call

LH : 255.82 (-1.44%)

Barchart Exclusives

Microsoft vs. Nvidia: Which AI Giant Is the Better Dividend Stock for the Long Haul?
Microsoft and NVIDIA are AI giants, but which stock is the better buy? Compare growth, valuation, dividends, and Wall Street ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.